Board Meeting Intimation for Audited Financial Results For The Quarter And Year Ended 31St March 2025
04:09 PM, 12th May 2025
Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 inter alia to consider and approve Audited Financial Results for the quarter and year ended 31st March 2025